Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MB

Mark Laurence Boys — 28 Patents

ABArray Biopharma: 13 patents #53 of 335Top 20%
PHPharmacia: 4 patents #268 of 1,582Top 20%
Pfizer: 3 patents #1,614 of 5,153Top 35%
GSG.D. Searle: 3 patents #254 of 659Top 40%
TPThesan Pharmaceuticals: 2 patents #2 of 7Top 30%
Bristol-Myers Squibb: 2 patents #1,827 of 3,969Top 50%
GPGraceway Pharmaceuticals.: 1 patents #11 of 21Top 55%
MPMedicon Pharmaceuticals: 1 patents #38 of 73Top 55%
Lyons, CO: #7 of 145 inventorsTop 5%
Colorado: #1,181 of 40,980 inventorsTop 3%
Overall (All Time): #134,628 of 4,157,543Top 4%
28 Patents All Time
Mark Laurence Boys has been granted 28 US patents while listed as an inventor at Array Biopharma. The first was granted in 1996 and the most recent in January 2025. Mark Laurence Boys ranks #134,628 of 4,157,543 US inventors in our database (top 3.2%). Patent records list Mark Laurence Boys in Lyons, CO, US.

Issued Patents All Time

Showing 1–25 of 28 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12187721 Protein tyrosine phosphatase inhibitors James F. Blake, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed, Jay Bradford Fell +6 more 2025-01-07
11884664 Protein tyrosine phosphatase inhibitors James F. Blake, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed, Jay Bradford Fell +7 more 2024-01-30
11834453 Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors Bryan Daniel ELLIS, John Gaudino, Erik James Hicken, Ellen Laird, Nicholas Charles LAZZARA +2 more 2023-12-05
11802127 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Joshua Ryan Dahlke, Alex Andrew KELLUM +3 more 2023-10-31 $284,263,000
11691973 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Sydney Taylor BLANCHE, Wesley Dewitt CLARK +9 more 2023-07-04
11634417 Protein tyrosine phosphatase inhibitors James F. Blake, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed, Jay Bradford Fell +7 more 2023-04-25
11247990 Bicyclic fused pyridine compounds as inhibitors of TAM kinases Shelley Allen, Adam Cook, John Gaudino, Ronald Jay Hinklin, Ellen Laird +4 more 2022-02-15
11028093 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Shelley Allen, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer, John Gaudino +13 more 2021-06-08
10730880 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors Shelley Allen, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer, John Gaudino +13 more 2020-08-04
10669269 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more 2020-06-02
10189845 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Shelley Allen, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer, John Gaudino +13 more 2019-01-29 $44,601,000
9938289 Therapeutic pyrazolyl thienopyridines Stephen Douglas Barrett, James Bernard Kramer, Huifen Chen 2018-04-10
9809590 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more 2017-11-07 $14,586,000
9260450 Therapeutic pyrazolyl thienopyridines Stephen Douglas Barrett, James Bernard Kramer, Huifen Chen 2016-02-16
9174981 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more 2015-11-03 $10,851,000
9090625 Therapeutic pyrazolyl thienopyridines Stephen Douglas Barrett, James Bernard Kramer, Huifen Chen 2015-07-28
8962596 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases Laurence E. Burgess, Robert D. Groneberg, Darren Harvey, Timothy Kercher, Christopher F. Kraser +4 more 2015-02-24 $17,811,000
8841455 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Michael Bradley, Robert Kirk DeLisle, D. David Hennings, April L. Kennedy, Fredrik P. Marmsater +7 more 2014-09-23 $3,108,000
8455512 Therapeutic pyrazolyl thienopyridines Stephen Douglas Barrett, James Bernard Kramer, Huifen Chen 2013-06-04
7964612 Therapeutic pyrazolyl thienopyridines Stephen Douglas Barrett, James Bernard Kramer, Huifen Chen 2011-06-21
7670613 Androgen modulators Lain-Yen Hu, Bruce Lefker, Daniel Y. Du, Yvonne Dorothy Smith, Huangshu Lei +3 more 2010-03-02 $207,756,000
7119098 Heteroarylakanoic acids as intergrin receptor antagonists Srinivasan Nagarajan, Ish Khanna, Michael B. Tollefson, Scott Mohler, Barbara Chen +7 more 2006-10-10
7115596 Thiazole compounds as integrin receptor antagonists derivatives John Adam Wendt, Heather Stenmark, Hongwei Wu, Yaping Wang, Barbara Chen +4 more 2006-10-03 $47,121,000
6933304 Heteroarylalkanoic acids as integrin receptor antagonists Srinivasan Nagarajan, Ish Khanna, Michael B. Tollefson, Scott Mohler, Barbara Chen +7 more 2005-08-23
6531494 Gem-substituted &agr;v&bgr;3 antagonists Ish Khanna, Yi Yu, Balekudru Devadas, Hwang-Fun Lu, Nizal Chandrakumar +12 more 2003-03-11 $98,856,000